Biopharmaceutical Research Company (BRC) welcomed Lucas Zumstein as the organization’s new Vice President of Operations this week.
Bringing over a decade of operations experience with him, Zumstein has spent the majority of his operations career in active pharmaceutical ingredient (API) development and pharmaceutical manufacturing. Previously he held roles with organizations such as Abzena, Noramco and Johnson & Johnson.
“Lucas is known as a collaborative leader who is willing to roll up his sleeves and work alongside his team,” Managing Partner John Wright said. “His understanding of process design paired with his team building skills will serve him well at Biopharmaceutical Research Company.”
Zumstein is responsible for production and manufacturing oversight at BRC and will develop and implement operational processes that foster growth. He will work closely with several other departments to ensure product compliance.
“Lucas is highly adaptable and results-oriented,” Managing Partner Janet Wightman said. “Able to communicate across a wide range of audiences, Lucas brings a proven track record of success to his new role with BRC.”
Founded in 2017, Biopharmaceutical Research Company is a federally certified producer and developer of botanical cannabinoid active pharmaceutical ingredients and plant-based therapeutics. The organization operates out of California with a team of former regulatory and law enforcement professionals, horticulture experts, academics and pharmaceutical manufacturers to ensure uncompromising quality for patients and researchers.
